Chatham Capital Group, Inc. Lemaitre Vascular Inc Transaction History
Chatham Capital Group, Inc.
- $595 Million
- Q4 2024
A detailed history of Chatham Capital Group, Inc. transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Chatham Capital Group, Inc. holds 48,489 shares of LMAT stock, worth $4.75 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
48,489
Previous 50,059
3.14%
Holding current value
$4.75 Million
Previous $4.65 Million
3.91%
% of portfolio
0.75%
Previous 0.77%
Shares
23 transactions
Others Institutions Holding LMAT
# of Institutions
300Shares Held
20.4MCall Options Held
5.2KPut Options Held
2.9K-
Black Rock Inc. New York, NY3.48MShares$341 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.69MShares$166 Million2.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$155 Million0.0% of portfolio
-
Copeland Capital Management, LLC1.17MShares$115 Million2.06% of portfolio
-
Geneva Capital Management LLC866KShares$84.8 Million1.4% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $2.15B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...